InvestSMART

Polynovo Limited (ASX:PNV)

ALERT: Price-sensitive ASX Announcement for PNV
Current share price for PNV : $0.960 -0.033 (-3.27%)+
Announcement
Release
20 Feb 2026 11:34AM
Price at Release
$0.993
Full Release
download
Summary
PolyNovo Limited reported its half-year financial performance for the period ending 31 December 2025, highlighting significant revenue growth despite challenges. The company's total revenue increased by 25.2% to A$75.0 million, driven by a 26.0% rise in group sales. U.S. sales specifically saw a 25.3% growth, and NovoSorb MTX sales surged by 195.2%. The company appointed a new CEO, Bruce Peatey, and completed the construction of an additional manufacturing facility. The net profit after tax was marginal at A$0.0 million due to a decrease in BARDA revenue and temporary manufacturing reductions. Nonetheless, EBITDA adjusted for significant items increased by 82.0%. The report also notes the impact of a fire incident, which led to an impairment loss and insurance claim income. PolyNovo continues its global expansion and product innovation efforts, particularly with NovoSorb BTM and MTX in various international markets.
Key Points
  • Group sales increased by 26.0% to A$68.2 million.
  • Net profit after tax was A$0.0 million, down from A$3.3 million in the previous period.
  • NovoSorb MTX sales in the U.S. rose by 195.2%.
  • The company completed a new manufacturing facility.
  • Appointed Bruce Peatey as CEO on 1 December 2025.
  • Total revenue including BARDA was A$75.0 million.
  • EBITDA adjusted for significant items was A$4.7 million, an increase of 82.0%.
  • Impact of fire incident led to an impairment loss and insurance claim income.
  • Global sales growth observed in North America, Europe, Asia, and Australia.
  • Ongoing efforts in product innovation and market expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.